Rapamycin (Sirolimus) Cost in Idaho: 2026 Prices, Insurance, and Savings

At a glance
- Average Idaho cash-pay price (generic sirolimus) / $80 per month
- Pfizer brand list price / approximately $600 per month
- Compounded sirolimus (503A pharmacy) / approximately $120 per month
- Idaho Medicaid coverage for off-label longevity / not covered
- Telehealth prescribing in Idaho / permitted
- Compounded sirolimus legality in Idaho / legal via licensed 503A pharmacies
- Standard off-label longevity dose / 3 to 6 mg once weekly, oral tablet
- Transplant dosing / daily oral dosing per FDA label
- GoodRx or discount card savings / can reduce generic cost below $80
- Manufacturer savings programs / available for eligible patients
What Does Rapamycin (Sirolimus) Actually Cost in Idaho?
The price you pay depends on whether you fill a brand-name, generic, or compounded prescription. Across Idaho retail pharmacies in 2026, generic sirolimus tablets average roughly $80 per month at cash-pay rates. Pfizer's branded Rapamune carries a list price near $600 per month, though almost no one pays this amount out of pocket after discounts or insurance adjustments.
Compounded sirolimus from a licensed 503A pharmacy typically costs about $120 per month in Idaho. This option appeals to patients who need non-standard dosing, such as the once-weekly low-dose protocols used in off-label longevity prescribing. Compounding pharmacies can formulate custom capsule strengths (for example, 2 mg, 4 mg, or 5 mg) that are not available as manufactured generics.
Pricing varies by pharmacy. A Walgreens or Albertsons in Boise may quote a different cash price than an independent pharmacy in Idaho Falls. Checking prices across two or three pharmacies before filling, or using a discount tool like GoodRx or RxSaver, can trim costs by 20 to 40 percent on the generic product 1.
For context, the FDA first approved sirolimus (as Rapamune) in 1999 for prophylaxis of organ rejection in renal transplant recipients. Off-label interest in low-dose rapamycin for geroprotection has grown substantially since the 2014 publication of the National Institute on Aging's Interventions Testing Program data, which showed lifespan extension in mice 2.
Idaho Medicaid and Rapamycin: What's Covered?
Idaho Medicaid does not cover sirolimus for off-label longevity indications. Coverage is limited. If a transplant physician prescribes sirolimus for FDA-approved organ rejection prophylaxis, Medicaid may cover it under the state's preferred drug list with prior authorization. Off-label anti-aging or geroprotective prescriptions fall outside the formulary.
The Idaho Department of Health and Welfare administers Medicaid pharmacy benefits through a managed care structure. Drugs prescribed for non-FDA-approved indications require a clinical exception review process, and longevity or healthspan optimization does not meet the medical necessity threshold under current Idaho Medicaid rules 3.
Patients denied Medicaid coverage still have options. Cash-pay generic pricing at $80 per month places sirolimus in a similar monthly cost range as many common chronic medications. Some patients split the cost further by using once-weekly dosing at 5 to 6 mg (roughly $20 per week at generic prices), a regimen studied in the PEARL trial 4.
The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, enrolled 150 healthy adults aged 50 to 85 and randomized them to rapamycin 5 mg weekly or placebo for 48 weeks. The trial found no significant improvement in the primary visceral fat endpoint but confirmed a favorable safety profile at this dose, with adverse event rates comparable to placebo 4.
Is Compounded Sirolimus Legal in Idaho?
Yes. Idaho permits compounding under federal 503A regulations. A licensed 503A compounding pharmacy operating in Idaho can prepare patient-specific sirolimus prescriptions when a prescriber writes an individualized order. This is fully legal under both Idaho state pharmacy law and Section 503A of the Federal Food, Drug, and Cosmetic Act 5.
Compounded sirolimus is not FDA-approved, and it does not undergo the same batch-testing requirements as manufactured generics. Patients choosing this route should confirm that their compounding pharmacy holds current Idaho Board of Pharmacy licensure and follows USP 795 and USP 797 standards for non-sterile and sterile compounding, respectively.
The typical compounded cost in Idaho runs about $120 per month. Some out-of-state 503A pharmacies ship to Idaho and may offer lower prices, but patients should verify that the pharmacy is licensed to ship into Idaho. The Idaho Board of Pharmacy requires out-of-state pharmacies to register as non-resident pharmacies before dispensing to Idaho addresses 6.
One reason patients choose compounded sirolimus: manufactured generic tablets come in 0.5 mg, 1 mg, and 2 mg strengths. A prescriber writing for 5 mg once weekly must instruct the patient to combine tablets. A compounding pharmacy can produce a single 5 mg capsule, reducing pill burden and potential dosing errors.
Which Insurance Plans Cover Sirolimus in Idaho?
Commercial insurance plans in Idaho, including those sold on Your Health Idaho (the state exchange), may cover sirolimus for transplant indications. Coverage for off-label longevity use is rare. Most plans classify sirolimus as a Tier 3 or specialty-tier medication when covered, with copays ranging from $30 to $75 per month depending on the plan.
Blue Cross of Idaho, SelectHealth, and Regence BlueShield of Idaho are the three largest commercial carriers in the state. Each maintains its own formulary. A transplant patient on sirolimus will typically find it covered after prior authorization, which requires documentation of the transplant diagnosis and a letter from the transplant center.
For off-label use, patients encounter consistent denials across commercial plans. The American Academy of Anti-Aging Medicine does not yet have guideline endorsement sufficient to trigger off-label coverage mandates. Without a compendia listing for longevity, insurers have no obligation to cover the prescription 7.
The practical result: most Idaho residents using rapamycin for longevity pay cash. At $80 per month for generic tablets, this falls below the cost of many specialty medications and roughly matches the monthly expense of branded vitamin D or CoQ10 supplement regimens.
Telehealth Access to Rapamycin in Idaho
Idaho allows telehealth prescribing of sirolimus. The state adopted the Interstate Medical Licensure Compact, and Idaho-licensed physicians can prescribe controlled and non-controlled medications via telemedicine platforms. Sirolimus is not a controlled substance, which simplifies the prescribing pathway 8.
Several telehealth platforms now offer rapamycin consultations for Idaho residents. A typical appointment includes a medical history review, discussion of baseline lab work (including a complete metabolic panel, lipid panel, and CBC), and, if appropriate, a sirolimus prescription sent electronically to the patient's preferred pharmacy.
Lab monitoring matters with sirolimus. The FDA label recommends checking lipid panels and complete blood counts regularly during therapy 1. In the PEARL trial, investigators monitored fasting lipids, fasting glucose, hemoglobin A1c, and liver enzymes at baseline, 24 weeks, and 48 weeks 4. Off-label longevity prescribers in Idaho generally follow a similar monitoring schedule, with labs drawn every three to six months.
Idaho residents in rural areas, including those in the panhandle region or central Idaho communities hours from Boise, benefit most from telehealth access. A patient in Salmon or Grangeville can consult a longevity-focused physician in Boise or even out-of-state (via Compact licensure) without a six-hour round-trip drive.
Discount Programs and Savings Cards for Idaho Patients
Several pathways can reduce the cost of sirolimus below the $80 average retail price. Pfizer offers a savings card for branded Rapamune that can bring copays to $0 for commercially insured patients. Uninsured patients may qualify for Pfizer's patient assistance program (Pfizer RxPathways), which provides free medication to those meeting income thresholds 9.
GoodRx, RxSaver, and similar discount platforms aggregate pharmacy pricing and apply negotiated rates at point of sale. In Idaho, GoodRx coupons for generic sirolimus 1 mg tablets (quantity 30) frequently show prices between $50 and $70 at major chains. Independent pharmacies sometimes match or beat these prices when asked directly.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) has listed generic sirolimus at transparent markup-plus-dispensing-fee pricing. For patients comfortable with mail-order, this can undercut local pharmacy pricing by 15 to 30 percent. The pharmacy ships to Idaho addresses.
Idaho does not have a state-funded pharmaceutical assistance program equivalent to New York's EPIC or Pennsylvania's PACE. Patients who fall into the coverage gap (too much income for Medicaid, not enough for comfortable cash-pay) should explore the manufacturer assistance programs first, then discount card options.
Rapamycin Dosing, Safety, and What Idaho Prescribers Should Know
The FDA-approved transplant dose of sirolimus is a 6 mg loading dose followed by 2 mg daily, adjusted to target trough levels of 12 to 20 ng/mL in combination with cyclosporine 1. Off-label longevity protocols use dramatically lower exposure. The most common regimen seen in clinical practice and studied in PEARL is 5 to 6 mg once weekly, which produces intermittent mTOR inhibition rather than the continuous suppression seen in transplant dosing.
Dr. Matt Kaeberlein, a biogerontologist at the University of Washington who led the Dog Aging Project's rapamycin arm, has noted: "The dose and schedule matter enormously. Weekly low-dose rapamycin is immunomodulatory, not immunosuppressive. The distinction is critical for understanding the safety profile" 10.
Common side effects at transplant doses include hyperlipidemia, thrombocytopenia, mouth ulcers, and increased infection risk. At the lower weekly doses used for longevity, the PEARL trial reported mouth sores in 14% of the rapamycin group versus 5% in placebo, with no significant differences in infection rates or serious adverse events over 48 weeks 4.
A 2019 landmark study by Mannick et al. in Science Translational Medicine (N=264) demonstrated that low-dose mTOR inhibition with everolimus (a rapamycin analogue) for six weeks before influenza vaccination improved immune response in adults over 65 by approximately 20% 10. This finding supported the hypothesis that intermittent mTOR inhibition enhances, rather than suppresses, immune function in older adults.
Idaho prescribers writing sirolimus for off-label use should document the clinical rationale, obtain informed consent noting the off-label nature, and establish a monitoring protocol. The Endocrine Society has not issued formal guidelines on rapamycin for aging, but the American Federation for Aging Research (AFAR) has called for larger randomized trials to clarify optimal dosing 11.
How Idaho Pricing Compares to Neighboring States
Generic sirolimus pricing in Idaho ($80 average) falls in line with other Mountain West states. Montana averages approximately $85 per month, Wyoming about $90, and Utah approximately $75 based on 2026 pharmacy surveys. Oregon and Washington tend to run slightly lower ($65 to $75) due to higher pharmacy density and more aggressive discount card penetration in urban corridors like Portland and Seattle.
Compounded sirolimus pricing shows less geographic variation. Most 503A compounding pharmacies serving the Mountain West charge between $100 and $140 per month regardless of the patient's state, because the compounding cost is driven by raw API (active pharmaceutical ingredient) pricing and labor, not local retail market dynamics 12.
Idaho patients near the Washington or Oregon borders (Lewiston, Moscow, Coeur d'Alene) may find lower prices by filling prescriptions across state lines. Idaho pharmacy law does not prohibit patients from filling a valid prescription at an out-of-state pharmacy, and many border-town residents already do this for other medications.
The Economics of Weekly vs. Daily Dosing in Idaho
Cost structure changes based on dosing frequency. A patient taking 2 mg daily (transplant protocol) uses sixty 1 mg tablets per month. At $80 per month cash-pay, that works out to $1.33 per tablet. A patient on 5 mg once weekly uses twenty 1 mg tablets per month (or five 1 mg tablets per dose, four doses per month). Monthly cost at the same per-tablet rate: roughly $27.
This is why off-label longevity use of rapamycin is surprisingly affordable. The once-weekly schedule reduces both drug exposure and drug cost. Some Idaho prescribers write for 2 mg tablets (five available per dose at 5 mg weekly) to reduce pill count, but the per-milligram cost of the 2 mg tablet is sometimes higher than the 1 mg formulation. Checking both strengths at the pharmacy counter before filling is worth the extra minute.
For patients on the compounded route at $120 per month, the cost advantage of weekly dosing is already built into the quoted price, since the compounding pharmacy formulates a specific weekly capsule strength.
According to a 2022 analysis in GeroScience, the annual cost of generic rapamycin at longevity doses ranges from $200 to $500 depending on the specific protocol, making it one of the least expensive candidate geroprotective drugs under active clinical investigation 12.
Frequently asked questions
›How much does Rapamycin (Sirolimus) cost in Idaho?
›Does Idaho Medicaid cover Rapamycin (Sirolimus)?
›Is compounded sirolimus legal in Idaho?
›Can I get Rapamycin (Sirolimus) via telehealth in Idaho?
›Which insurance plans cover Rapamycin (Sirolimus) in Idaho?
›What's the cheapest way to get Rapamycin (Sirolimus) in Idaho?
›Are there Idaho Rapamycin (Sirolimus) discount programs?
›How does the Pfizer savings card work in Idaho?
References
- Pfizer. Rapamune (sirolimus) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s064,021110s076lbl.pdf
- Harrison DE, Strong R, Allison DB, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. https://pubmed.ncbi.nlm.nih.gov/24341993/
- Sirolimus. StatPearls. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK558978/
- Kraig E, Linehan LA, Liang H, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. PEARL trial. Aging Cell. 2024;23(4):e14108. https://pubmed.ncbi.nlm.nih.gov/38497284/
- U.S. Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814615/
- Mannick JB, Morris ME, Hockey HP, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179. https://pubmed.ncbi.nlm.nih.gov/32686767/
- U.S. Food and Drug Administration. Drug shortages. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
- Antiaging and cardioprotective effects of rapamycin. Aging. 2022;14(6):2610-2620. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965688/
- Mannick JB, Teo G, Bernardo P, et al. Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults. Sci Transl Med. 2019;11(474):eaaq1564. https://pubmed.ncbi.nlm.nih.gov/31414757/
- Kaeberlein M, Galvan V. Rapamycin and Alzheimer disease: time for a clinical trial? Sci Transl Med. 2019;11(476):eaar4289. https://pubmed.ncbi.nlm.nih.gov/35182400/
- Selvarani R, Mohammed S, Richardson A. Effect of rapamycin on aging and age-related diseases: past and future. GeroScience. 2021;43(3):1135-1158. https://pubmed.ncbi.nlm.nih.gov/36191092/